|
SPRO Spero Therapeutics Inc 1701108 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-9,552,000.00 |
| Balance Sheet |
|
Current Assets
|
$51,584,000.00 |
|
Assets
|
$52,766,000.00 |
|
Current Liabilities
|
$8,428,000.00 |
|
Liabilities
|
$8,562,000.00 |
|
Equity
|
$44,204,000.00 |
|
Shares Out
|
58146910.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$10,509,000.00 |
| Market Analysis |
Market Cap
|
$70,357,761.10 |
|
Price
|
$1.21 |
|
BVPS
|
0.76 |
|
PB
|
1.59 |
|
EPS
|
-0.16 |
|
PE
|
13.10 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:50 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:40 |
|
| Apr |
May |
Jun |
| 2026-03-26 |
0.53 |
|
|
2026-05-13 |
-0.13 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.03 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.13 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SPRO documents filed with the SEC.
SPRO Filings
Clear
